Acquired <i>MET</i> Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in <i>EGFR</i> -Mutated Lung Cancer
- DOI
- 10.1200/po.19.00011
- Published
- 2019-12
- Container
- JCO Precision Oncology
- Publisher
- American Society of Clinical Oncology (ASCO)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1200/po.19.00011,
title = {Acquired
<i>MET</i>
Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in
<i>EGFR</i>
-Mutated Lung Cancer},
author = {Ken Suzawa and Michael Offin and Adam J. Schoenfeld and Andrew J. Plodkowski and Igor Odintsov and Daniel Lu and William W. Lockwood and Maria E. Arcila and Charles M. Rudin and Alexander Drilon and Helena A. Yu and Gregory J. Riely and Romel Somwar and Marc Ladanyi},
year = {2019},
journal = {JCO Precision Oncology},
doi = {10.1200/po.19.00011},
url = {https://doi.org/10.1200/po.19.00011}
}RIS
TY - JOUR
TI - Acquired
<i>MET</i>
Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in
<i>EGFR</i>
-Mutated Lung Cancer
AU - Ken Suzawa
AU - Michael Offin
AU - Adam J. Schoenfeld
AU - Andrew J. Plodkowski
AU - Igor Odintsov
AU - Daniel Lu
AU - William W. Lockwood
AU - Maria E. Arcila
AU - Charles M. Rudin
AU - Alexander Drilon
AU - Helena A. Yu
AU - Gregory J. Riely
AU - Romel Somwar
AU - Marc Ladanyi
PY - 2019
JO - JCO Precision Oncology
DO - 10.1200/po.19.00011
UR - https://doi.org/10.1200/po.19.00011
ER - APA
Suzawa, K., Offin, M., Schoenfeld, A. J., Plodkowski, A. J., Odintsov, I., Lu, D., Lockwood, W. W., Arcila, M. E., Rudin, C. M., Drilon, A., Yu, H. A., Riely, G. J., Somwar, R., & Ladanyi, M. (2019). Acquired <i>MET</i> Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in <i>EGFR</i> -Mutated Lung Cancer. JCO Precision Oncology. https://doi.org/10.1200/po.19.00011
Source records
- crossref · retrieved 2026-09-27T02:17:35.993Z